The same way that epipen got so expensive: Executives wanted a larger bonus while lacking the ability to otherwise meet unreasonable “infinite growth” demands

The same way that epipen got so expensive: Executives wanted a larger bonus while lacking the ability to otherwise meet unreasonable “infinite growth” demands of the market.